Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Methods Of Healthcare Delivery System

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...

Modified-Release Drug Delivery Systems: Influencing Factors

Modified-Release Drug Delivery Systems: Influencing Factors

Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

On the vaccine supply chain coordination under subsidy contract.

Vaccine·2021

Same author

Novel 1,3,4-thiadiazoles inhibit colorectal cancer via blockade of IL-6/COX-2 mediated JAK2/STAT3 signals as evidenced through data-based mathematical modeling.

Cytokine·2018

Same author

Poly(lactic-<i>co</i>-glycolic acid)-loaded nanoparticles of betulinic acid for improved treatment of hepatic cancer: characterization, in vitro and in vivo evaluations.

International journal of nanomedicine·2018

Same author

Complicated jejunal diverticulitis with unusual presentation.

Radiology case reports·2018

Same author

Novel fused oxazepino-indoles (FOIs) attenuate liver carcinogenesis via IL-6/JAK2/STAT3 signaling blockade as evidenced through data-based mathematical modeling.

Life sciences·2018

Same author

Transcriptomic signature of drought response in pearl millet (Pennisetum glaucum (L.) and development of web-genomic resources.

Scientific reports·2018

Search research articles

Related Experiment Video

Updated: Feb 19, 2026

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

A fuzzy MICMAC analysis for improving supply chain performance of basic vaccines in developing countries.

Dheeraj Chandra¹, Dinesh Kumar¹

¹a Department of Mechanical and Industrial Engineering , Indian Institute of Technology Roorkee , Roorkee , India.

Expert Review of Vaccines

|November 9, 2017

Summary

Improving child immunization requires addressing vaccine supply chain issues. Better demand forecasting, communication, and planning are critical for enhancing vaccine availability and delivery performance.

Keywords:

Vaccine developing countries factors fuzzy MICMAC immunization issues supply chain

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

Related Experiment Videos

Last Updated: Feb 19, 2026

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

Area of Science:

Supply Chain Management
Public Health
Vaccinology

Background:

The global vaccine market is increasingly complex due to rising demand for child immunization and advancements in vaccine technology.
Complexities in the vaccine supply chain lead to performance issues, hindering effective immunization coverage.

Purpose of the Study:

To identify and analyze critical issues within the supply chain of essential vaccines for child immunization in developing countries.
To understand the root causes of poor vaccine supply chain performance.

Main Methods:

A comprehensive list of twenty-five key factors influencing the vaccine supply chain was compiled.
Fuzzy MICMAC analysis was employed to classify these factors based on driving and dependence power, establishing a hierarchical model.
Findings were validated through discussions with field experts to pinpoint critical factors.

Main Results:

Three pivotal factors were identified as critical to vaccine supply chain performance: improved demand forecasting, enhanced communication among supply chain members, and optimized planning and scheduling.
These factors were determined to have the most significant impact on the overall efficiency of the vaccine supply chain.

Conclusions:

Addressing demand forecasting, inter-member communication, and planning/scheduling is essential for improving vaccine supply chain performance.
Focusing on these critical factors can lead to more reliable vaccine availability for child immunization programs.